Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Mono- and biallelic variant effects on disease at biobank scale

Submitted by Frida Mäkelä on Fri, 09/30/2022 - 13:26
  • Read more about Mono- and biallelic variant effects on disease at biobank scale

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes

Submitted by Frida Mäkelä on Fri, 09/30/2022 - 13:20
  • Read more about Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes

Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 09/30/2022 - 13:14
  • Read more about Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study

Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases

Submitted by Frida Mäkelä on Fri, 09/30/2022 - 12:03
  • Read more about Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases

Polygenic risk score from a multi-ancestry GWAS uncovers susceptibility of heart failure

Submitted by Frida Mäkelä on Fri, 09/30/2022 - 09:47
  • Read more about Polygenic risk score from a multi-ancestry GWAS uncovers susceptibility of heart failure

Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

Submitted by Frida Mäkelä on Fri, 09/30/2022 - 09:26
  • Read more about Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 15:51
  • Read more about Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics

Genome-wide association studies highlight novel risk loci for septal defects and left-sided congenital heart defects

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 15:44
  • Read more about Genome-wide association studies highlight novel risk loci for septal defects and left-sided congenital heart defects

Genetic risk factors have a substantial impact on healthy life years

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 15:37
  • Read more about Genetic risk factors have a substantial impact on healthy life years

Research Letter: Genetically determined blood pressure traits are associated with increased risk of aortic dissection: a Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 15:27
  • Read more about Research Letter: Genetically determined blood pressure traits are associated with increased risk of aortic dissection: a Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 485
  • Page 486
  • Page 487
  • Page 488
  • Current page 489
  • Page 490
  • Page 491
  • Page 492
  • Page 493
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement